Summit Therapeutics (SMMT) Goodwill & Intangibles (2017 - 2026)

Summit Therapeutics (SMMT) has reported Goodwill & Intangibles for 10 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

• Quarterly Goodwill & Intangibles fell 3.48% year-over-year to $2.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.0 million (down 3.48% YoY) and the FY2025 annual result came in at $2.0 million, up 7.35% from the prior year.
• Goodwill & Intangibles held at $2.0 million in Q2 2026 per SMMT's latest filing, from $2.0 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for SMMT reached as high as $11.8 million in Q1 2022 and fell as low as $1.8 million in Q4 2022.
• A 5-year average of $3.4 million and a median of $1.9 million in 2025 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles tumbled 85.51% — and 2024, when it increased 9.76%.
• Year by year, Goodwill & Intangibles stood at $1.8 million in 2022, then rose by 5.28% to $1.9 million in 2023, then retreated by 1.53% to $1.9 million in 2024, then gained by 7.35% to $2.0 million in 2025, then dropped by 1.65% to $2.0 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $2.0 million, $2.0 million, and $2.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.